TXA11114: Discovery of an <i>In Vivo</i> Efficacious Efflux Pump Inhibitor (EPI) That Potentiates Levofloxacin Against <i>Pseudomonas aeruginosa</i>

<b>Objectives:</b> Multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i> represents a major clinical challenge, driven in part by resistance–nodulation–division (RND) efflux pumps that reduce intracellular antibiotic concentrations and limit the efficacy of many antibacterial agents, including flu...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jesus D. Rosado-Lugo, Pratik Datta, Ahmad Altiti, Yongzheng Zhang, Jun Lu, Yi Yuan, Ajit K. Parhi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2026-03-01
Ráidu:	Antibiotics
Fáttát:	<i>P. aeruginosa</i> RND efflux pumps antimicrobial drug resistance efflux pump inhibitor indole carboxamide <i>in vivo</i> efficacy
Liŋkkat:	https://www.mdpi.com/2079-6382/15/4/346
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!